Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes.
Jaehyun BaeYoung-Eun KimMinyoung LeeEun Young LeeByung-Wan LeeBong Soo ChaEun Seok KangPublished in: Yonsei medical journal (2022)
Adding SGLT-2 inhibitors is not inferior to adding SU as a third-line ADD to metformin plus DPP-4 inhibitor combination therapy.